NCT00482391 Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer Status COMPLETED Phase PHASE2
NCT00480506 Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major Status COMPLETED Phase N/A
NCT00476476 Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar Status COMPLETED Phase PHASE2
NCT00476177 Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant Status COMPLETED Phase PHASE1
NCT00476086 Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus Status COMPLETED Phase PHASE2
NCT00474994 Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas Status COMPLETED Phase PHASE2
NCT00465023 Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer or Hepatic Metastases Status COMPLETED Phase NA
NCT00459186 The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00459069 The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00459043 Docetaxel in Combination With Zactima (ZD6474) in Patients With Locally Advanced Squamous Cell Carcinoma of the the Head and Neck Status COMPLETED Phase PHASE2
NCT00458653 Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT00458549 Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery Status TERMINATED Phase NA
NCT00458536 Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF Status COMPLETED Phase PHASE1/PHASE2
NCT00458237 Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00455897 CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00455624 Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer Status COMPLETED Phase N/A
NCT00448721 A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer Status COMPLETED Phase PHASE2
NCT00442130 Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination Status COMPLETED Phase PHASE1
NCT00441142 Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors Status COMPLETED Phase PHASE1/PHASE2